Pediatric Heart Failure clinical trials

Explore recruiting pediatric heart failure clinical trials.

Recruiting pediatric heart failure studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pediatric Heart Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(21467) A Phase 3, single-arm, open-label extension study to evaluate the safety of finerenone in addition to standard of care, in pediatric heart failure patients, from birth to 18 years of age, with left ventricular systolic dysfunction (LVSD)

Czechia, Germany, Greece, Italy, Finland, Bulgaria +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pediatric Heart Failure trials by city

Pediatric Heart Failure clinical trials

Recruiting pediatric heart failure studies right now

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients

At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Simulation Trial of Telemedical Support for Paramedics

MedlyPeds Feasibility Study

HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

Also recruiting in Europe

(21467) A Phase 3, single-arm, open-label extension study to evaluate the safety of finerenone in addition to standard of care, in pediatric heart failure patients, from birth to 18 years of age, with left ventricular systolic dysfunction (LVSD)

Pediatric Heart Failure trials by city

Other conditions